Accenture plc (NYSE:ACN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 9.01 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On April 11, 2018, the Board of Directors (the “Board”) of Accenture plc (the “Company”) appointed Venkata S.M. “Murthy” Renduchintala as a new director of the Company, effective April 12, 2018, upon the recommendation of the Board’s Nominating& Governance Committee. Dr. Renduchintala will serve until the Company’s 2019 annual general meeting of shareholders, when he will be subject to re-appointment by a vote of the Company’s shareholders.

Dr. Renduchintala, 52, is chief engineering officer and president of the Client and Internet of Things (IoT) Businesses and Systems Architecture group and the Technology and Manufacturing group at Intel Corporation. In his current role at Intel, he is responsible for aligning technology, engineering, product design and process development to drive execution across all of Intel’s businesses. He also provides business direction to extend Intel’s strategy across its client and connectivity businesses. Before joining Intel in 2015, Dr. Renduchintala was executive vice president of Qualcomm Technologies Inc. and co-president of Qualcomm CDMA Technologies, where he led the semiconductor business in the computing and mobile segments. He joined Qualcomm in 2004 from Skyworks Solutions, where he was vice president and general manager of the Cellular Systems division. Prior to Skyworks, he spent a decade with Philips Electronics, progressing to become vice president of engineering for its consumer communications business.

Dr. Renduchintala holds a bachelor’s degree in electrical engineering, a master’s degree in business administration and a Ph.D. in digital communications from the University of Bradford in England.

Dr. Renduchintala has been appointed to serve on the Board’s Audit Committee. He will receive the pro rata portion of the standard compensation for service on the Board (currently $100,000 per annum) and the Audit Committee (currently $15,000 per annum), based on the number of days remaining in the current director compensation year. Dr. Renduchintala may elect to receive his compensation in cash or equity. He will also receive the standard grant of restricted share units valued at $200,000 made by the Company to directors newly appointed to the Board.

The Company expects Dr. Renduchintala to enter into the Company’s standard indemnification agreement for its directors.

A copy of the Company’s news release issued on April 12, 2018 regarding the appointment of Dr. Renduchintala to the Board is filed as Exhibit 99 to this Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits

Accenture plc Exhibit
EX-99 2 a2018-04x12x8xkex.htm NEWS RELEASE OF ACCENTURE,…
To view the full exhibit click here

About Accenture plc (NYSE:ACN)

Accenture plc is a professional services company serving clients in various industries and in geographic regions, including North America, Europe and Growth Markets. The Company provides management and technology consulting services. Its segments include Communications, Media and Technology; Financial Services; Health and Public Service; Products, and Resources. The Communications, Media & Technology segment serves communications, electronics, technology, media and entertainment industries. The Financial Services segment serves banking, capital markets and insurance industries. The Health & Public service segment serves healthcare payers and providers, and government departments and agencies, public service organizations, educational institutions and non-profit organizations. The Products segment serves a set of interconnected consumer-relevant industries. The Resources segment serves chemicals, energy, forest products, metals and mining, utilities and related industries.